Skip to main navigation About Us Products Newsroom Careers Investors En Investors We take seriously the trust our shareholders place in us to deliver on our mission. Explore our earnings reports, investor events and stock information to learn more about our commitment to global healthcare. NASDAQ stock price Last Updated: Nov 30, 2021 1:46 PM EST $12.31 -0.21 (-1.68%) Data Provided by Refinitiv. Minimum 15 minutes delayed. News Nov. 18, 2021 Viatris to Participate in Evercore ISI 4th Annual HealthCONx Conference Learn more Nov. 16, 2021 Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection Learn more Nov. 11, 2021 Viatris Donates $1 Million as Founding Champion to New Orleans-based SBP's "Got Your Back" fund in Support of Housing Solutions for Veterans in Disaster-Impacted Communities Learn more Explore press releases Events & presentations December 1, 2021 at 7:30 AM EST 4th Annual Evercore ISI HealthCONx Conference Go to webcast November 8, 2021 at 10:00 AM EST Third Quarter 2021 Financial Results Go to webcast Browse all events Third Quarter 2021 Financial Results Webcast Press Release Earnings Presentation Q3 2021 Non-GAAP Reconciliations Featured documents 2021 Proxy Statement Form 10-K Our leaders Our seasoned executive management team and board of directors bring decades of expertise, knowledge and strategic vision to Viatris. Meet our leaders Corporate governance Viatris is a publicly traded company that is managed and controlled under the oversight of the company’s board of directors. Learn more about the guidelines, committee charters and other documents that describe our corporate governance framework. Learn more Corporate responsibility As we work to help patients live healthier at every stage of life, we continue to advance responsible and sustainable operations, recognizing that our actions affect the stakeholders and communities we serve. Learn more FAQs Browse our list of questions frequently asked by investors or reach out to our team for more information about Viatris. Investor-related FAQs Email alerts Contact us LinkedIn Footer Links Column1 Viatris Privacy Notice Cookie Notice Terms of use Footer Links Column2 Contact Us California Supplemental Disclosure California Supply Chain Transparency, UK and Australia Modern Slavery Statement Footer Links Column3 Sitemap About Us Products Footer Links Column4 Careers Investors Newsroom Cookies Settings Follow Us ©2021 Viatris Inc. All Rights Reserved. The Viatris logo is a registered trademark of Mylan Inc, a Viatris company. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies